NIMH Chemical Synthesis and Drug Supply Program

Compound Information Page

Compound Name: (2S,3S,4R,5R,E)-N-Ethyl-3,4-dihydroxy-5-(6-(4-(6-(2-(4-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxy)acetamido)hexanamido)butylamino)-9H-purin-9-yl)-tetrahydrofuran-2-carboxamide (ABEA-X-BY630)
NIMH Code: A-910
Alternative Name: ABEA-X-BY630
Abbreviation:
Indications: Red-emitting fluorescent adenosine receptor agonist
Package Sizes:
References: 1) Middleton, R. J.; Briddon, S. J.; Cordeaux, Y.; Yates, A. S.; Dale, C. L.; George, M. W.; Baker, J. G.; Hill, S. J.; Kellam, B. J. Med. Chem. 2007, 50, 782-793. 2) Cordeaux, Y.; Briddon, S. J.; Alexander, S. P.; Kellam, B.; Hill, S. J. FASEB J. 2008, 22, 850-860.
CAS:
Molecular Formula:
HBA:
HBD:
RotB:
PubChemID:
AlogP:
TPSA:
Activity:
Comments:
Last Updated 2010-04-21 11:15 AM
Structure of A-910
About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».